C-reactive protein levels in the first three hours after acute cerebral infarction

Massimo Camerlingo1, Laura Valente, Marcello Tognozzi

  • 1Policlinico San Marco, Neurology, Osio Sotto, Bergamo, Italy. tfield@med.miami.edu

Insights

C-reactive protein (CRP) levels are significantly elevated within 3 hours of an acute ischemic stroke. This early increase in CRP is independently associated with stroke, suggesting its role in early cerebral infarction.

Area of Science:

  • Neurology
  • Biochemistry
  • Inflammation Markers

Background:

  • C-reactive protein (CRP) is implicated in acute ischemic stroke.
  • Early investigation of CRP in cerebral infarction is limited.

Purpose of the Study:

  • To investigate C-reactive protein (CRP) levels in the initial hours of acute ischemic stroke.
  • To determine if CRP is an independent predictor of early stroke.

Main Methods:

  • CRP levels were measured in 387 acute ischemic stroke patients within 3 hours of symptom onset.
  • A control group of 387 age- and sex-matched inpatients was included.
  • Statistical analysis involved multiple logistic regression.

Main Results:

  • Stroke patients exhibited significantly higher CRP levels (median 5.0 mg/L) compared to controls (median 1.9 mg/L).
  • CRP remained a significant independent variable associated with stroke in regression analysis.
  • No significant differences in sex or mean age (66 years) between groups.

Conclusions:

  • C-reactive protein (CRP) is demonstrably increased within the first 3 hours of an acute ischemic stroke.
  • Early elevation of CRP is significantly associated with acute ischemic stroke.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...